Given prolonged uncertainties relating to the Russia-Ukraine conflict, difficult near-term conditions in China, and sustained inflationary pressures keeping the Federal Reserve and other major central banks on a hawkish path, our macroeconomics team has lowered our 2022 global growth forecast from 3.7% to 3.3%.
Asia as well will suffer a significant hit from the deterioration of global conditions, not least because of its close economic ties with China, which is suffering a considerable hit to consumption and productivity due to difficulties imposing a zero-Covid policy against the spread of Omicron.
As a result of weaker growth prospects, in our asset allocation breakdown within Asia, we downgrade our rating for Indonesia from Overweight to Neutral, and our rating for South Korea from Neutral to Underweight.
Downgrading South Korea and Indonesia equities
We are downgrading South Korea from Neutral to Underweight given the headwinds facing the Korean economy.
Within the Korean tech sector, which forms a significant weight in the MSCI Korea Index, we are seeing more foreign funds outflow and are cautious of the softening PC and smartphone markets within the hardware segment, and the potential impact they could have on memory demand. This is likely due to the broader macro headwinds such as rate hikes, inflation and geopolitical risks.
Operational complexities could also arise given the lengthening supply lead times for companies to receive critical semiconductor equipment due to bottlenecks. Within the internet space, we believe that higher-than-expected costs could start to weigh on operating profits. In our view, wage hikes driven by inflation and competition for talent appear to be the common thread across a number of companies. As such, we think this theme could start to be reflected in a meaningful way in management commentaries moving forward.
We are also downgrading Indonesia from Overweight to Neutral. Indonesia has strongly outperformed the MSCI World Index since our recent upgrade. Given weaker growth prospects, however – in part due to the wider ban of palm oil exports to include crude palm oil and refined products which would impact export revenue – and less compelling equity valuations following the recent outperformance, we downgrade our rating for Indonesia to Neutral to lock in gains.
Long term prospects for China and Singapore equities remain firm
The recent disappointing set of stimulus measures from China led our macroeconomics team to lower our 2022 GDP growth forecast for China from 5.5% to 4.8%.
Broadly, we believe that Chinese policy makers will find it difficult to achieve its trinity of goals: 5.5% GDP growth, zero Covid cases, and limiting the leverage in its economy, especially if the People’s Bank of China further rations stimulus in view of the inflation and currency risks arising from a divergence in monetary policy versus the Fed.
While this weakens the thesis for our overweight position in Chinese equities at the margin, we see our long-term thesis to be broadly intact given overly depressed valuations and a still-constructive long-term outlook.
Outside of Greater China, we continue to like Singapore for its relatively defensive nature and higher dividend yield. Singapore recently announced the further easing of its community Safe Management Measures (SMMs), such as the elimination of group size limits, simplification of its Vaccinated Travel Framework and capacity limits being lifted for all events except nightlife establishments. This came into effect on 26 Apr 2022 and should help to support its international reopening and economic recovery.
Banner image source: AFP
Important information
This product may only be offered: (i) in Hong Kong, to qualified Private Banking Customers and Professional Investors (as defined under the Securities and Futures Ordinance); and (ii) in Singapore, to Accredited Investors (as defined under the Securities and Futures Act) and (iii) in the Dubai International Financial Center to Professional Clients (as defined under the Dubai Financial Services Authority rules) only. No other person should act on the contents of this document.This product may involve derivatives. Do NOT invest in it unless you fully understand and are willing to assume the risks associated with it. If you have any doubt, you should seek independent professional financial, tax and/or legal advice as you deem necessary.
Please carefully read and make sure that you understand all Risk Disclosures, Selling Restrictions, and Disclaimers. This document must be read together with the relevant Prospectus & Offering Documents &/or Key Fact Statement.
Disclaimer
This document is prepared by Bank of Singapore Limited (Co Reg. No.: 197700866R) (the “Bank”), is for information purposes only, and is not, by itself, intended for anyone other than the recipient. It may contain information proprietary to the Bank which may not be reproduced or redistributed in whole or in part without the Bank’s prior consent. It is not an offer or a solicitation to deal in any of the investment products referred to herein or to enter into any legal relations, nor an advice or by itself a recommendation with respect to such investment products. It does not have regard to the specific investment objectives, investment experience, financial situation and the particular needs of any recipient or customer. Customers should exercise caution in relation to any potential investment. Customers should independently evaluate each investment product and consider the suitability of such investment product, taking into account customer’s own specific investment objectives, investment experience, financial situation and/or particular needs. Customers will need to decide on their own as to whether or not the contents of this document are suitable for them. If a customer is in doubt about the contents of this document and/or the suitability of any investment products mentioned in this document for the customer, the customer should obtain independent financial, legal and/or tax advice from its professional advisers as necessary, before proceeding to make any investments.
The Bank, its Affiliates and their respective employees are not in the business of providing, and do not provide, tax, accounting or legal advice to any clients. The material contained herein is prepared for informational purposes and is not intended or written to be used, and cannot be used or relied upon for tax, accounting or legal advice. Any such client is responsible for consulting his/her own independent advisor as to the tax, accounting and legal consequences associated with his/her investments/transactions based on the client’s particular circumstances.
This document and other related documents have not been reviewed by, registered or lodged as a prospectus, information memorandum or profile statement with the Monetary Authority of Singapore nor any regulator in Hong Kong or elsewhere.
This document may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Bank’s prior written consent. This document is not intended for distribution to, publication or use by any person in any jurisdiction outside Singapore, Hong Kong, or such other jurisdiction as the Bank may determine in its absolute discretion, where such distribution, publication or use would be contrary to applicable law or would subject the Bank and its related corporations, connected persons, associated persons and/or affiliates (collectively, “Affiliates”) to any registration, licensing or other requirements within such jurisdiction.
